The 50 rating InvestorsObserver gives to Hepion Pharmaceuticals Inc (HEPA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 81 percent of stocks in the Biotechnology industry, HEPA’s 50 overall rating means the stock scores better than 50 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 50 means the stock is more attractive than 50 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Hepion Pharmaceuticals Inc Stock Today?
Hepion Pharmaceuticals Inc (HEPA) stock is trading at $2.15 as of 11:03 AM on Friday, Jun 11, a drop of -$0.11, or -4.87% from the previous closing price of $2.26. The stock has traded between $2.12 and $2.27 so far today. Volume today is 1,665,848 compared to average volume of 1,928,251.
Click Here to get the full Stock Score Report on Hepion Pharmaceuticals Inc (HEPA) Stock.
